Rani Therapeutics Statistics
NASDAQ: RANIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.5111-0.0695 (-11.97%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Rani Therapeutics by the numbers
Rani Therapeutics has a market capitalization of $59.0 million based on 115.49M shares outstanding. With trailing EPS of $-0.06, Rani Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.6% below its 50-day average and 41.7% below its 200-day average.
Average daily trading volume is 545.67K shares, or about $278,892 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RANI valuation vs. peer median
| Metric | RANI | Peer median | Difference |
|---|---|---|---|
| Market cap | $59.03M | $56.30M | +5% |
| Avg. volume | 545.67K | 206.41K | +164% |
Peer median across 8 companies: TENX, IBIO, KZIA, VTVT, AZR, BOLD, FBIO, XLO.
Valuation
- Market cap
- $59.03M
- Price / sales (latest FY)
- 36.15
- EPS (TTM)
- $-0.06
- Shares outstanding
- 115.49M
Price and trading
- Previous close
- 0.5806
- Open
- 0.58
- Day range
- 0.5101 – 0.5819
- 52-week range
- 0.502 – 1.69
- 52-week change
- -68.64%
- 200-day moving average
- 0.8767
- Beta
- —
- Volume
- 457.42K
- Average volume
- 545.67K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 59.03M
- Forward Pe
- -2.69
- Eps
- -0.06
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.69
- Week52 Low
- 0.50
- Avg Volume
- 545.67K
- Shares Outstanding
- 115.49M
- Ma50
- 0.68
- Ma200
- 0.88
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -69.76%
- Pct From52w Low
- 1.81%